Pharmafile Logo

Jon Hume Joins Cuttsy+Cuttsy as New Commercial Director

Cuttsy+Cuttsy is excited to announce the appointment of Jon Hume as Commercial Director, effective 1st March 2024.

Photo of Jon in Cuttsy+Cuttsy branded shapes

Over the last two decades, Jon has gained extensive experience in agency commercial roles, client services, and strategy. He has worked closely with senior client stakeholders, building successful relationships, developing key accounts, creating new products, and scaling agency teams. Alongside his comprehensive healthcare experience, Jon also enriches C+C with his expertise in digital and FMCG sectors.

In 2020, Jon was honoured in the BIMA 100 list as one of the leaders, pioneers, entrepreneurs, and changemakers leading the digital sector, recognising his achievements in building and leading agency client services and project management teams.

Caroline Benson, Co-Founder, says, “Having worked with Jon over the last year, he is already a valued member of the C+C family. We are thrilled he has joined the team in a full-time capacity.”

Mathew Cutts adds, “For the last four years, we have been strengthening our leadership team in line with our growth. Jon joins us to help continue our growth plans and contribute to keeping the business aligned with ever-changing technologies, while remaining true to our ‘people first’ value.”

Jon Hume expresses, “After closely collaborating with C+C and their fantastic clients throughout most of 2023, I am privileged to take the next step and join this talented team. Their work significantly impacts patient lives every day, and I am eager to contribute.”

This content was provided by Cuttsy + Cuttsy

Company Details

 Latest Content from  Cuttsy + Cuttsy 

Clinical trial considerations: Why digital matters…

Digital technology in healthcare is rapidly evolving. In this blog we delve into how digital solutions can help improve patient experience within clinical trials.

Clinical trials explained: Why imagery matters…

Recruiting patients for clinical trials is one of pharma's greatest challenges. Imagery is a great way to connect with people on an emotional level and forms a big part the...

Clinical trials explained: Why health literacy matters…

Clinical trial recruitment can be a challenge. By applying the principles of health literacy to all materials, we can support people to make an informed choice about whether to take...

Clinical trials explained: Why iconography matters…

Icons serve as a useful form of alternative communication. We spend a lot of time developing icons for healthcare communications. Find out how we use iconography to elevate clinical trial...

Cuttsy+Cuttsy appoints Harriet Karia as Managing Director

Cuttsy+Cuttsy is pleased to announce the appointment of Harriet Karia as its first Managing Director.

Using generative AI in healthcare comms – our promise to our clients

It’s safe to say one of the hottest topics of 2023 has been ChatGPT and the launch of other Generative AI-driven applications. So, we’re sharing our promises, so that when...

Clinical trials explained: Why colour matters…

Colour can be used to emphasise mood, evoke emotions, and determine first impressions of a brand. Find how to use colour effectively in your next clinical trial campaign.

Clinical trials explained: Why branding matters…

With nearly a decade’s experience supporting clinical trials, find out why we think humanising trials through design is so important.

DPHARM2023 – Five key themes impacting clinical trials today

Throughout three fascinating days of conference, some key themes emerged that are impacting study teams and the effectiveness of their clinical trials on a daily basis.

Flexible working: a fad or the future?

As the Flexible Working Bill gets written into UK law, we took a look at what this means for businesses of all sizes and specialities.